“…Eighteen clinical case reports of pregabalin misuse or abuse were identified and were from the United States (Filipetto, Zipp, & Coren, 2010), Turkey (Aksakal, Bakirci, Emet, & Uzkeser, 2012; Aldemir, Altıntoprak, & Coşkunol, 2015; Sonmez, 2015; Yargic & Ozdemiroglu, 2011), Austria (Yazdi, Hemetsberger, & Baier, 2015), France (Driot et al, 2016), Greece (Papazisis, Garyfallos, Sardeli, & Kouvelas, 2013), Germany (Gahr et al, 2013; Grosshans et al, 2010; Olaizola et al, 2006; Skopp & Zimmer, 2011), Italy (Carrus & Schifano, 2012), the United Kingdom (Braga & Chidley, 2007; Wood, Berry, Glover, Eastwood, & Dargan, 2010), India (Tandon, Mahajan, Gillani, & Mahajan, 2013), Ireland (Osman & Casey, 2014), and Lebanon (Halaby, Abou Kassm, & Naja, 2015). Thirty-six publications were obtained as peer reviewed journal articles from Germany (Bonnet & Scherbaum, 2017; Gahr, Freudenmann, Kölle, & Schönfeldt-Lecuona, 2014), the United Kingdom (Baird, Fox, & Colvin, 2013; Eastwood & Davison, 2016; Kapil, Green, Le Lait, Wood, & Dargan, 2014; Loftus & Wright, 2014; Schifano et al, 2011), the United States (Papazisis & Tzachanis, 2014; Wilens, Zulauf, Ryland, Carrellas, & Catalina-Wellington, 2014; Zacny, Paice, & Coalson, 2012), Finland (Kriikku et al, 2014), Jordan (Al-Husseini et al, 2017; Wazaify, Abood, Tahaineh, & Albsoul-Younes, 2017), and Italy (Martinotti, 2012), and as reports from Germany (Cossmann, Scherbaum, & Bonnet, 2016; Freynhagen et al, 2016; Gahr et al, 2013; Grosshans et al, 2013), the United Kingdom (Asomaning et al, 2016; Millar, Sadasivan, Weatherup, & Lutton, 2013; Schifano, 2014), Sweden (Bodén, Wettermark, Brandt, & Kieler, 2014; …”